Contents
Osage University Partners (OUP) is a Pennsylvania venture capital firm founded in 2009.
OUP seeks to invest in companies founded by scientists, academics and students in software, hardware, therapeutics, medical devices and diagnostics sectors.
The company's portfolio includes Artizan Biosciences, Cleave Therapeutics, Cyteir Therapeutics, Everactive, IonQ, Landos Biopharma, Menlo Security, Menlo Security, PMV Pharmaceuticals and SiFive, etc.
OUP manages $600M and is investing out of a $273M fund as of November 2019.
Timeline
No Timeline data yet.
Further Resources
Title
Author
Link
Type
Date
Osage University Partners Raises Third Fund For University Research Spinouts
Web
References
Company attributes
Founder
Pitchbook URL
Full Address
50 Monument Road
Suite 201
Bala Cynwyd, PA 19004
Investors
Founded Date
2009
Email Address
mediarelations@oup.vc
info@oup.vc
Key People
Also Known As
OUP
NAICS Code
52,523
Venture Capital Firm attributes
Other attributes
Company Operating Status
Active
